Thermo Fisher Scientific (TMO) said Tuesday that it has agreed to acquire Solventum's (SOLV) Purification & Filtration business for $4.1 billion in cash.
Thermo said the deal, which is set to be completed by the end of the year, is expected to be dilutive to adjusted EPS by $0.06.
In a separate statement, Solventum said it expects the deal to be neutral to EPS this year.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。